Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases

被引:4
|
作者
Netzahualcoyotzi, Citlalli [1 ,2 ,5 ]
Santillan-Cigales, Juan Jair [1 ]
Adalid-Peralta, Laura Virginia [2 ]
Velasco, Ivan [1 ,2 ,3 ,4 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City, Mexico
[2] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, Mexico
[4] Inst Nacl Neurol & Neurocirugia Manuel Velasco Sua, Lab Reprogramac Celular, Mexico City 14269, Mexico
[5] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Farmacol, Mexico City, Mexico
关键词
Alzheimer's disease; blood-brain barrier; leukocytes; neuroimmunology; neurovascular unit; Parkinson's disease; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PROTEIN; CD8; T-CELLS; ALZHEIMERS-DISEASE; MAST-CELLS; MOUSE MODEL; IFN-GAMMA; BARRIER PERMEABILITY; NEUROVASCULAR UNIT; MICROGLIAL ACTIVATION;
D O I
10.1111/jnc.16106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurovascular unit, composed of vascular endothelium, vascular smooth muscle, extracellular matrix components, pericytes, astrocytes, microglia, and neurons, allows the highly regulated exchange of molecules and the limited trafficking of cells to the brain through coordinated signaling activity. The passage of peripheral immune cells to the brain parenchyma is observed when there is clear damage to the barriers of this neurovascular unit, as occurs in traumatic brain injury. The possibility of leukocyte infiltration to the brain in neurodegenerative conditions has been proposed. In this review, we focus on describing the evidence for peripheral immune cell infiltration to the brain in the two most frequent neurodegenerative diseases: Alzheimer's and Parkinson's diseases. In particular, we address the mechanisms that promote the passage of these cells into the brain under such pathological conditions. We also discuss the relevance of the resulting cellular interactions, which provide evidence that the presence of peripheral immune cells in the brain is a key point in these neurodegenerative diseases. The disruption of the neurovascular unit and the infiltration of the peripheral immune cells into the central nervous system are hallmarks of neurodegenerative diseases. However, so far, the participation of infiltrating cells in the progression of these diseases has not been completely defined. In this work, we gather the evidence that exists until now which proposes the key events involved in the pathogenesis of the two main neurodegenerative diseases: Alzheimer's and Parkinson's diseases. We detail the alterations in the components that typically keep the neurovascular unit semi-permeable to the cellular interactions that promote a self-perpetuating cycle of inflammation.image
引用
收藏
页码:2316 / 2334
页数:19
相关论文
共 50 条
  • [31] Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
    Ahmed, Tanvir
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (11) : 2915 - 2954
  • [32] Discriminant accuracy of standing balance tests for level of gait dependency in hospitalized patients with Alzheimer's disease
    Nakagawa, Keita
    Kanai, Shusaku
    Kitakaze, Sosuke
    Okamura, Hitoshi
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2024, 53 (03) : 135 - 142
  • [33] Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise
    Lopez, Danielle C.
    White, Zachary J.
    Hall, Stephanie E.
    ALZHEIMERS & DEMENTIA, 2024, 20 (05) : 3543 - 3550
  • [34] Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation
    Dorsey, E. Ray
    Kinel, Dan
    Pawlik, Meghan E.
    Zafar, Maryam
    Lettenberger, Samantha E.
    Coffey, Madeleine
    Auinger, Peggy
    Hylton, Kevin L.
    Shaw, Carol W.
    Adams, Jamie L.
    Barbano, Richard
    Braun, Melanie K.
    Schwarz, Heidi B.
    Lawrence, B. Paige
    Kieburtz, Karl
    Tanner, Caroline M.
    de Miranda, Briana R.
    Goldman, Samuel M.
    MOVEMENT DISORDERS, 2024, 39 (03) : 606 - 613
  • [35] Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases
    Maruszak, Aleksandra
    Gaweda-Walerych, Katarzyna
    Soltyszewski, Ireneusz
    Kekanowski, Cezary
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2006, 66 (02) : 153 - 176
  • [36] Preliminary translation of 'Reducing Disability in Alzheimer's Disease' among individuals with intellectual disabilities and caregiver dyads
    Ptomey, Lauren T.
    Barton, Kelli
    Swinford, Emma
    Bodde, Amy
    George, Amanda
    Gorczyca, Anna M.
    Niedens, C. Michelle
    Sprague, Susan C.
    Yeager, Amy
    Helsel, Brian
    Teri, Linda
    Vidoni, Eric D.
    Perales-Puchalt, Jaime
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2024, 37 (03)
  • [37] In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer's disease like pathology
    Manogna, Chintalapati
    Margesan, Thirumal
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [38] A novel method for PET connectomics guided by fibre-tracking MRI: Application to Alzheimer's disease
    Sun, Zhuopin
    Naismith, Sharon L.
    Meikle, Steven
    Calamante, Fernando
    HUMAN BRAIN MAPPING, 2024, 45 (04)
  • [39] A multi-omics study to monitor senescence-associated secretory phenotypes of Alzheimer's disease
    Yang, Jingzhi
    Zhou, Yinge
    Wang, Tianjiao
    Li, Na
    Chao, Yufan
    Gao, Songyan
    Zhang, Qun
    Wu, Shuo
    Zhao, Liang
    Dong, Xin
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (05): : 1310 - 1324
  • [40] Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach
    Marras, Connie
    Fereshtehnejad, Seyed-Mohammad
    Berg, Daniela
    Bohnen, Nicolaas I.
    Dujardin, Kathy
    Erro, Roberto
    Espay, Alberto J.
    Halliday, Glenda
    Van Hilten, Jacobus J.
    Hu, Michele T.
    Jeon, Beomseok
    Klein, Christine
    Leentjens, Albert F. G.
    Mollenhauer, Brit
    Postuma, Ronald B.
    Rodriguez-Violante, Mayela
    Simuni, Tanya
    Weintraub, Daniel
    Lawton, Michael
    Mestre, Tiago A.
    MOVEMENT DISORDERS, 2024, 39 (03) : 462 - 471